• Mon. Nov 4th, 2024

‘Dr. Reddy’s Launches Succinylcholine Chloride Injection In US

Dr. Reddy’s To Acquire Select Brands From Glenmark In Russia, UkraineDr. Reddy’s To Acquire Select Brands From Glenmark In Russia, Ukraine

Hyderabad, Nov.13 (Hydnow): Dr. Reddy’s Laboratories yesterday announced the launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), in the US Market.

Dr. Reddy’s Laboratories along with its subsidiaries, announced the launch of Succinylocholine Chloride Injection USP,200mg/ 10ml (20 mg/ML) Multiple-Dose Vials a therapeutic equivalent generic version of Quelicin (Succinylcholine Chloride) Injection, 20 mg/mL, approved by the U.S. Food and Drug Administration (USFDA).

The Quelicin brand and generic market had U.S. sales of approximately $74.8 million MAT for the most recent twelve months ending in September 2020 according to IQVIA Health.

Advertisements

Dr. Reddy’s Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), is available in multi-dose vials. (Hydnow)

Leave a Reply

Your email address will not be published. Required fields are marked *